ClinicalTrials.Veeva

Menu

User Performance Evaluation of an Investigational Blood Glucose Monitoring System

Ascensia Diabetes Care logo

Ascensia Diabetes Care

Status

Completed

Conditions

Diabetes

Treatments

Device: Ninja 2 Investigational Blood Glucose Monitoring System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01410773
R&D-2010-2011.32

Details and patient eligibility

About

The purpose of this study is to demonstrate that untrained subjects with diabetes can use an investigational Blood Glucose Monitoring System (BGMS) with capillary blood obtained from fingerstick and from Alternative Site (AST) Palm .

Enrollment

110 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females, 18 years of age and above
  • Diagnosed as having type 1 or type 2 diabetes
  • Currently self-testing blood glucose at home
  • Able to speak, read, and understand English
  • Willing to complete all study procedures

Exclusion criteria

  • Blood Borne infections like hepatitis or HIV or infections such as tuberculosis
  • Hemophilia or any other bleeding disorder
  • Employee of competitive medical device company,immediate family member of such, or living within the household of such
  • Pregnancy

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

110 participants in 1 patient group

Intended Users of the System
Experimental group
Description:
Untrained subjects with diabetes (at least 70% of subjects will be insulin users) use an investigational blood glucose monitoring system (Ninja 2) to self-test capillary blood obtained from fingerstick and palm.
Treatment:
Device: Ninja 2 Investigational Blood Glucose Monitoring System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems